These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10500088)

  • 1. Setback for systemic therapy of esophageal cancer: right concept, disappointing result.
    O'Sullivan GC; Shanahan F; Talwalkar J; Van Dam J
    Gastroenterology; 1999 Oct; 117(4):1020-2. PubMed ID: 10500088
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical resection with and without chemotherapy in oesophageal cancer.
    Bosset JF; Mercier M; Triboulet JP; Conroy T; Seitz JF
    Lancet; 2002 Oct; 360(9340):1173-4; author reply 1175. PubMed ID: 12387978
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical resection with and without chemotherapy in oesophageal cancer.
    Rath GK; Sharma DN; Shukla NK
    Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387980
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical resection with and without chemotherapy in oesophageal cancer.
    Chander S
    Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
    [No Abstract]   [Full Text] [Related]  

  • 5. Esophageal cancer preoperative chemotherapy--can we justify what we do?
    Wallace MB; Hawes RH; Hoffman BJ
    Am J Gastroenterol; 1999 Sep; 94(9):2562-3. PubMed ID: 10484029
    [No Abstract]   [Full Text] [Related]  

  • 6. Resectable esophageal cancer: surgery as primary therapy is not the answer, but then, what is and why?
    Ajani JA
    J Clin Oncol; 2010 May; 28(15):e243-4; author reply e245. PubMed ID: 20368554
    [No Abstract]   [Full Text] [Related]  

  • 7. Should resectable esophageal cancer be resected?
    Mariette C; Triboulet JP
    Ann Surg Oncol; 2006 Apr; 13(4):447-9. PubMed ID: 16485145
    [No Abstract]   [Full Text] [Related]  

  • 8. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
    Chua YJ; Cunningham D
    Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
    [No Abstract]   [Full Text] [Related]  

  • 9. New approaches to treating oesophageal cancer.
    O'Reilly S; Forastiere A
    BMJ; 1994 May; 308(6939):1249-50. PubMed ID: 8205011
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical resection with and without chemotherapy in oesophageal cancer.
    Maraveyas A; O'Boyle C; Cowen M
    Lancet; 2002 Oct; 360(9340):1174-5; author reply 1175. PubMed ID: 12387981
    [No Abstract]   [Full Text] [Related]  

  • 11. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
    Briasoulis E; Fatouros M; Roukos DH
    Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative chemoradiation for esophageal cancer.
    Burtness BA
    Cancer J Sci Am; 1999; 5(2):73-4. PubMed ID: 10198727
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant radiotherapy and radiochemotherapy in the management of esophageal cancer: a review of the literature.
    Carcaterrra M; Osti MF; De Sanctis V; Caruso C; Berardi F; Enrici RM
    Rays; 2005; 30(4):319-22. PubMed ID: 16792007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined-modality treatment of esophageal cancer.
    Urba S
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 9):63-7. PubMed ID: 9330411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problematic results of a randomized study of neoadjuvant radiochemotherapy of operable esophageal carcinoma].
    Fietkau R; Kundt G
    Strahlenther Onkol; 2001 Jul; 177(7):372-3. PubMed ID: 11505624
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of induction therapy in esophageal cancer.
    Cellini F; Ramella S; Ciresa M; Porziella V; Meacci E; Fiore M; Trodella L; D'Angelillo RM
    Rays; 2005; 30(4):329-33. PubMed ID: 16792009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality therapy of esophageal cancer: changes in the standard of care?
    Shah MA; Kelsen DP
    Ann Surg Oncol; 2004 Jul; 11(7):641-3. PubMed ID: 15197008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phase III clinical trial for esophageal cancer using radiotherapy].
    Ogino T
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):341-9. PubMed ID: 7533489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
    Shinoda M; Hatooka S; Mori S; Mitsudomi T
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modality therapy in the treatment of esophageal cancer.
    Ilson DH; Kelsen DP
    Semin Oncol; 1994 Aug; 21(4):493-507. PubMed ID: 8042047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.